Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9 | 8 | 9 | N/A | 6 |
| Other current assets | 0 | 0 | 0 | 0 | 119 |
| TOTAL | $9 | $8 | $9 | $N/A | $124 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 6 | N/A | 9 |
| Intangibles | 14 | 14 | 14 | 0 | 0 |
| TOTAL | $14 | $14 | $20 | $N/A | $9 |
| Total Assets | $23 | $22 | $29 | $N/A | $134 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12 | 56 | 101 | 0 | 77 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 61 |
| TOTAL | $12 | $56 | $101 | $N/A | $373 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 273 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 69 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $341 |
| Total Liabilities | $12 | $56 | $101 | $N/A | $714 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,192 | 2,161 | 41,654 | 41,466 | 36,592 |
| Common Shares | 22 | 22 | 417 | N/A | 156 |
| Retained earnings | -22,188 | -22,175 | -21,812 | N/A | -19,124 |
| Other shareholders' equity | -5 | -13 | -200 | 0 | -2,335 |
| TOTAL | $11 | $-34 | $-73 | $N/A | $-580 |
| Total Liabilities And Equity | $23 | $22 | $29 | $0 | $134 |